Knockdown of PAF1 reduces cervical cancer cell proliferation, migration and invasion via retarding FLOT2-mediated MEK/ERK1/2 pathway

References

• Johnson CA, James D, Marzan A, et al. Cervical cancer: an overview of pathophysiology and management. Semin Oncol Nurs. 2019;35(2):166–174. doi: 10.1016/j.soncn.2019.02.003
   PubMed Web of Science ®Google Scholar
• Tsikouras P, Zervoudis S, Manav B, et al. Cervical cancer: screening, diagnosis and staging. Journal Of BUON: Official Journal Of The Balkan Union Of Oncology. 2016;21(2):320–325.
   PubMed Web of Science ®Google Scholar
• Pimple SA, Mishra GA. Global strategies for cervical cancer prevention and screening. Minerva Ginecol. 2019;71(4):313–320. doi: 10.23736/S0026-4784.19.04397-1
   PubMed Web of Science ®Google Scholar
• Fang J, Zhang H, Jin S. Epigenetics and cervical cancer: from pathogenesis to therapy. Tumour Biol. 2014;35(6):5083–5093. doi: 10.1007/s13277-014-1737-z
   PubMedGoogle Scholar
• Olthof ER, van der Velden J, Painter RC, et al. Morbidity of radical hysterectomy combined with caesarean section in pregnant patients with cervical cancer. Eur J Gynaecol Oncol. 2021;42(2):300–306.
   Web of Science ®Google Scholar
• Li H, Wu X, Cheng X. Advances in diagnosis and treatment of metastatic cervical cancer. J Gynecol Oncol. 2016;27(4):e43. doi: 10.3802/jgo.2016.27.e43
   PubMed Web of Science ®Google Scholar
• Duan J-Q, Huang H-G, Shui C-L, et al. The cardioprotective effect of dexmedetomidine on elderly patients with cervical cancer in the trendelenburg position. Signa Vitae. 2021;17(5):117–121.
   Web of Science ®Google Scholar
• Karmakar S, Dey P, Vaz AP, et al. PD2/PAF1 at the crossroads of the cancer network. Cancer Res. 2018;78(2):313–319. doi: 10.1158/0008-5472.CAN-17-2175
   PubMed Web of Science ®Google Scholar
• Jaehning JA. The Paf1 complex: platform or player in RNA polymerase II transcription? Biochim Biophys Acta Gene Regul Mech. 2010;1799(5–6):379–388. doi: 10.1016/j.bbagrm.2010.01.001
   PubMed Web of Science ®Google Scholar
• Belotserkovskaya R, Reinberg D. Facts about FACT and transcript elongation through chromatin. Curr Opin Genet Dev. 2004;14(2):139–146. doi: 10.1016/j.gde.2004.02.004
   PubMed Web of Science ®Google Scholar
• Nimmakayala RK, Seshacharyulu P, Lakshmanan I, et al. Cigarette smoke induces stem cell features of pancreatic cancer cells via PAF1. Gastroenterology. 2018;155(3):892–908.e896. doi: 10.1053/j.gastro.2018.05.041
   PubMed Web of Science ®Google Scholar
• Rauth S, Karmakar S, Shah A, et al. SUMO modification of PAF1/PD2 enables PML interaction and promotes radiation resistance in pancreatic ductal adenocarcinoma. Mol Cell Biol. 2021;41(12):e0013521. doi: 10.1128/MCB.00135-21
   PubMed Web of Science ®Google Scholar
• Zhi X, Giroux-Leprieur E, Wislez M, et al. Human RNA polymerase II associated factor 1 complex promotes tumorigenesis by activating c-MYC transcription in non-small cell lung cancer. Biochem Biophys Res Commun. 2015;465(4):685–690. doi: 10.1016/j.bbrc.2015.08.017
   PubMed Web of Science ®Google Scholar
• Zheng JJ, He Y, Liu Y, et al. Novel role of PAF1 in attenuating radiosensitivity in cervical cancer by inhibiting IER5 transcription. Radiat Oncol. 2020;15(1):131. doi: 10.1186/s13014-020-01580-w
   PubMed Web of Science ®Google Scholar
• Liu FT, Qu QG, Zhu ZM. Up-regulation of flot-2 protein is related to lymph node metastasis and poor prognosis in human solid tumors. Minerva Chir. 2017;72(2):146–156. doi: 10.23736/S0026-4733.16.07261-8
   PubMed Web of Science ®Google Scholar
• Banning A, Kurrle N, Meister M, et al. Flotillins in receptor tyrosine kinase signaling and cancer. Cells. 2014;3(1):129–149. doi: 10.3390/cells3010129
   PubMedGoogle Scholar
• Zhao F, Zhang J, Liu YS, et al. Research advances on flotillins. Virol J. 2011;8(1):479. doi: 10.1186/1743-422X-8-479
   PubMedGoogle Scholar
• Liu L XX, Wang WD, Zhu L, et al. Roles of flotillins in tumors. J Zhejiang Univ Sci B. 2018;19(3):171–182.
   PubMed Web of Science ®Google Scholar
• Deng Y, Ge P, Tian T, et al. Prognostic value of flotillins (flotillin-1 and flotillin-2) in human cancers: a meta-analysis. Clin Chim Acta. 2018;481:90–98. doi: 10.1016/j.cca.2018.02.036
   PubMed Web of Science ®Google Scholar
• Her E-J, Kwon H, Chae B, et al. High D-dimer is a predictor for short-term mortality in patients with active cancer and acute pulmonary embolism. Signa Vitae. 2021;17(5):58–63.
   Web of Science ®Google Scholar
• Karmakar S, Rauth S, Nallasamy P, et al. RNA polymerase II-Associated factor 1 regulates stem cell features of pancreatic cancer cells, independently of the PAF1 complex, via interactions with PHF5A and DDX3. Gastroenterology. 2020;159(5):1898–1915.e. doi: 10.1053/j.gastro.2020.07.053
   PubMed Web of Science ®Google Scholar
• Wu X, Zhong Y, Chen Q, et al. Enhancer of mRNA decapping protein 4 (EDC4) interacts with replication protein a (RPA) and contributes to Cisplatin resistance in cervical cancer by alleviating DNA damage. Hereditas. 2020;157(1):41. doi: 10.1186/s41065-020-00154-w
   PubMed Web of Science ®Google Scholar
• Deng M, Cai X, Long L, et al. CD36 promotes the epithelial–mesenchymal transition and metastasis in cervical cancer by interacting with TGF-β. J Transl Med. 2019;17(1):352. doi: 10.1186/s12967-019-2098-6
   PubMed Web of Science ®Google Scholar
• Yang Z, Sun Q, Guo J, et al. GRSF1-mediated MIR-G-1 promotes malignant behavior and nuclear autophagy by directly upregulating TMED5 and LMNB1 in cervical cancer cells. Autophagy. 2019;15(4):668–685. doi: 10.1080/15548627.2018.1539590
   PubMed Web of Science ®Google Scholar
• Wu Y, Gu TT, Zheng PS. CIP2A cooperates with H-Ras to promote epithelial-mesenchymal transition in cervical-cancer progression. Cancer Lett. 2015;356(2 Pt B):646–655. doi: 10.1016/j.canlet.2014.10.013
   PubMed Web of Science ®Google Scholar
• Wang F, Huang W, Hu X, et al. Transcription factor AP-2β suppresses cervical cancer cell proliferation by promoting the degradation of its interaction partner β-catenin. molecular carcinogenesis. Mol Carcinog. 2017;56(8):1909–1923. doi: 10.1002/mc.22646
   PubMed Web of Science ®Google Scholar
• Zhong C, Zheng F, Ye S, et al. Effect of FLOT2 gene expression on invasion and metastasis of colorectal cancer and its molecular mechanism under Nanotechnology and RNA interference. Bio Med Res Int. 2022;2022:1–11. doi: 10.1155/2022/2897338
   Google Scholar
• Xu H, Yan X, Zhu H, et al. TBL1X and Flot2 form a positive feedback loop to promote metastasis in nasopharyngeal carcinoma. Int J Biol Sci. 2022;18(3):1134–1149. doi: 10.7150/ijbs.68091
   PubMed Web of Science ®Google Scholar
• Song T, Hu Z, Liu J, et al. FLOT2 upregulation promotes growth and invasion by interacting and stabilizing EphA2 in gliomas. Biochem Biophys Res Commun. 2021;548:67–73. doi: 10.1016/j.bbrc.2021.02.062
   PubMed Web of Science ®Google Scholar
• Xiao B, Zhang X, Li X, et al. Circ_001569 regulates FLOT2 expression to promote the proliferation, migration, invasion and EMT of osteosarcoma cells through sponging miR-185-5p. Open Life Sciences. 2020;15(1):476–487. doi: 10.1515/biol-2020-0050
   PubMed Web of Science ®Google Scholar
• Li Q, Peng J, Li X, et al. Liu T: miR-449a targets Flot2 and inhibits gastric cancer invasion by inhibiting TGF-β-mediated EMT. Diagn Pathol. 2015;10:202. doi: 10.1186/s13000-015-0435-5
   PubMed Web of Science ®Google Scholar
• Wu L, Wang Z, Li X, et al. Autophagy mediates bronchial cell malignant transformation induced by chronic arsenic exposure via MEK/ERK1/2 pathway. Toxicol Lett. 2020;332:155–163. doi: 10.1016/j.toxlet.2020.06.006
   PubMed Web of Science ®Google Scholar
• Wang J XX, Yang HT, Luo H, et al. Overexpression of glutathione S-transferase P1 inhibits the viability and motility of prostate cancer via targeting MYC and inactivating the MEK/ERK1/2 pathways. Oncol Res. 2017. doi: 10.3727/096504017X14978850961299
   Google Scholar
• Liu S, Chu B, Cai C, et al. DGCR5 promotes gallbladder cancer by sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK pathways. J Cancer. 2020;11(18):5466–5477. doi: 10.7150/jca.46351
   PubMed Web of Science ®Google Scholar
• Fu Y, Jin R-R, Li Y-L, et al. Isocorydine inhibits the proliferation of human endometrial carcinoma HEC-1B cells by downregulating the Ras/MEK/ERK signaling pathway. Eur J Gynaecol Oncol. 2021;42(3):548–553.
   Web of Science ®Google Scholar